The Pharmaceutical Research and Manufacturers of America has waded into the mifepristone controversy by filing an amicus brief – along with other industry stakeholders – asking for a reversal of a lower court decision in Alliance for Hippocratic Medicine v. the U.S. Food and Drug Administration.

There’s an uptick of adoption of ChatGPT, and its role and that of generative AI will expand over time, says the Chartis Group’s Director Gregg Mohrmann and Principal Bret Anderson.  

Health systems need to think about demand, service and supply, says Tom Kiesau, chief innovation officer and digital leader at the Chartis Group.

Envision Healthcare was awarded more than $91 million by an independent arbitration panel on March 30, in its arbitration against UnitedHealthcare for underpayment of essential medical care, the company revealed this week. In addition to the award, the panel will separately assess prejudgment interest and decide Envision’s entitlement to attorney’s fees, costs, and expenses as […]

While private motor vehicles are the primary form of transportation in the U.S., many people – including those in urban areas, Black or Hispanic people and those with low incomes – rely on public transportation.